tiprankstipranks
Trending News
More News >
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
US Market

Galectin Therapeutics (GALT) Income Statement

Compare
602 Followers

Galectin Therapeutics Income Statement

Last quarter (Q1 2025), Galectin Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Galectin Therapeutics's net income was $-9.63M. See Galectin Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -33.00K$ -32.00K$ -41.00K$ -36.00K
Operating Expenses
$ 42.43M$ 38.04M$ 38.35M$ 30.18M$ 23.44M
Depreciation and Amortization
$ 37.00K$ 33.00K$ 32.00K$ 41.00K$ 36.00K
EBITDA
$ -41.47M$ -38.24M$ -38.27M$ -30.00M$ -23.34M
Operating Income
$ -42.43M$ -38.07M$ -38.35M$ -30.18M$ -23.44M
Other Income/Expenses
$ -4.61M$ -2.99M$ -424.00K$ -348.00K$ -21.00K
Pretax Income
$ -47.05M$ -41.07M$ -38.78M$ -30.53M$ -23.46M
Net Income
$ -47.05M$ -41.07M$ -38.78M$ -30.53M$ -23.46M
Per Share Metrics
Basic EPS
$ -0.76$ -0.74$ -0.65$ -0.52$ -0.41
Diluted EPS
$ -0.76$ -0.74$ -0.65$ -0.52$ -0.41
Weighted Average Shares Outstanding
62.31M 60.16M 59.39M 58.53M 57.03M
Weighted Average Shares Outstanding (Diluted)
62.31M 60.16M 59.39M 58.53M 57.03M
Currency in USD

Galectin Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis